http://pressroom.prlog.org/Immuneresponsebio/Immune Response BioPharma, Inc. Latest Press Releases http://www.prlog.org/12140235-immune-response-biopharma-inc-sets-pricing-of-remune-vaccine-in-thailand-between-75-100-per-dose.htmlImmune Response BioPharma, Inc. Sets Pricing of REMUNE Vaccine in Thailand Between $75-100 Per Dose for Emergency Approval of HIV/AIDS VaccineSun, 19 May 2013 06:13:35 GMT http://www.prlog.org/12122820-immune-response-biopharma-inc-to-seek-emergency-approval-of-remune-in-thailand.htmlImmune Response BioPharma, Inc. to Seek Emergency Approval of REMUNE in Thailand & Begin Stockpiling HIV/AIDS VaccineMon, 22 Apr 2013 04:50:56 GMT http://www.prlog.org/12097702-immune-response-biopharma-inc-to-seek-orphan-designation-of-neurovax-for-pediatric-ms.htmlImmune Response BioPharma, Inc. to Seek Orphan Designation of NeuroVax for Pediatric Multiple Sclerosis to Expand Use of Novel Vaccine Treatment. Immune Response BioPharma, Inc.Wed, 13 Mar 2013 07:20:17 GMT http://www.prlog.org/12073824-immune-response-biopharma-inc-selects-american-stock-transfer-trust-as-transfer-agent-of-record.htmlImmune Response BioPharma, Inc. Selects the American Stock Transfer & Trust Company as Transfer Agent of Record.Tue, 05 Feb 2013 16:45:40 GMT http://www.prlog.org/12054924-immune-response-biopharma-inc-posts-2nd-half-2012-full-year-results.htmlImmune Response BioPharma, Inc. Posts 2nd Half 2012 & Full Year ResultsTue, 08 Jan 2013 04:50:07 GMT http://www.prlog.org/12044245-immune-response-biopharma-inc-files-for-orphan-designation-of-remune-for-pediatric-hivaids.htmlImmune Response BioPharma, Inc. Files for Orphan Designation of REMUNE for Pediatric HIV/AIDSMon, 17 Dec 2012 08:47:43 GMT http://www.prlog.org/12040504-immune-response-biopharma-inc-new-zorcell-psoriasis-vaccine-phase-iib-study-safety-efficacy.htmlImmune Response BioPharma, Inc. Announces New ZORCELL Psoriasis Vaccine Phase IIb Study Safety & Efficacy 350 Patients ZORCELL + Methotrexate 6 Months Study.Tue, 11 Dec 2012 03:21:06 GMT http://www.prlog.org/12028587-immune-response-biopharma-inc-adopts-shareholder-rights-plan-poison-pill.htmlImmune Response BioPharma, Inc. Adopts Shareholder Rights Plan & Poison Pill Anti-Takeover ProvisionThu, 22 Nov 2012 03:29:08 GMT http://www.prlog.org/12015187-immune-response-biopharma-inc-to-develop-zorcell-the-first-psoriasis-vaccine.htmlImmune Response BioPharma, Inc. to Develop Zorcell Psoriasis Vaccine the First Vaccine for Psoriasis & Reviews Phase II ResultsSat, 03 Nov 2012 10:21:52 GMT http://www.prlog.org/12012807-immune-response-biopharma-inc-remune-effective-07-hiv-progression-vs-6-full-806-study-results.htmlImmune Response BioPharma, Inc. Publishes Phase III Full 806 Study Results, REMUNE Very Effective Demonstrating 0.7% HIV Progression vs 6% Estimated Rate & Subgroup Median Virologic Failure Delayed by 20 Weeks In REMUNE Group.Wed, 31 Oct 2012 11:07:42 GMT http://www.prlog.org/12006070-immune-response-biopharma-inc-files-for-orphan-designation-of-ravax-for-juvenile-ra.htmlImmune Response BioPharma, Inc. Files for Orphan Designation of Blockbuster RA Vaccine RAVAX for expanded use into the rare disease Juvenile Rheumatoid Arthritis.Tue, 23 Oct 2012 04:24:50 GMT http://www.prlog.org/11989720-immune-response-biopharma-inc-files-for-orphan-designation-for-neurovax-for-multiple-sclerosis.htmlImmune Response BioPharma, Inc. Files for Orphan Designation for Blockbuster Drug NeuroVax for Multiple SclerosisWed, 03 Oct 2012 00:54:03 GMT http://www.prlog.org/11986297-immune-response-biopharma-inc-business-update-sees-blockbuster-ms-neurovax-partnership-by-q1-2013.htmlImmune Response BioPharma, Inc. Provides Business Update Sees Blockbuster MS Drug NeuroVax the Gold Standard of Care for MS and a Partnership by the end of Q1 2013Fri, 28 Sep 2012 06:29:25 GMT http://www.prlog.org/11982962-remune-effectiveness-extends-years-after-inoculation-remune-patient-has-2-healthy-hiv-free-children.htmlREMUNE Effectiveness Extends Years After Inoculation REMUNE Injected Patient Has 2 Healthy HIV Free Children Proving the Vaccine has Strong Immune Responses a Decade LaterTue, 25 Sep 2012 06:46:40 GMT http://www.prlog.org/11956641-immune-response-biopharma-inc-sees-first-year-remune-sales-north-of-1-billion-dollars.htmlImmune Response BioPharma, Inc. Sees First Year REMUNE Sales North of $1 Billion DollarsThu, 23 Aug 2012 04:25:15 GMT http://www.prlog.org/11923386-immune-response-biopharma-inc-review-of-blockbuster-ravax-phase-2b-study-patients-50-improvement.htmlImmune Response BioPharma, Inc. Review of Blockbuster RA Vaccine RAVAX Phase 2B 340 Patient Study Results Demonstrated a 50% Improvement in Patients Vaccinated with RAVAX.Fri, 13 Jul 2012 04:40:41 GMT http://www.prlog.org/11917251-immune-response-biopharma-inc-provides-blockbuster-ravax-phase-iii-study-in-ra-update.htmlImmune Response BioPharma, Inc. Provides Blockbuster RAVAX Phase III Study in RA Update With Inadequate Response to Humira or Enbrel now Available at www.immuneresponse.netFri, 06 Jul 2012 00:54:36 GMT http://www.prlog.org/11907877-immune-response-biopharma-inc-announces-formulation-changes-to-blockbuster-ra-drug-ravax.htmlImmune Response BioPharma, Inc. Announces Formulation Changes to Blockbuster RA Drug RAVAX Adds 4th Peptide for Potent RA VaccineMon, 25 Jun 2012 05:30:25 GMT http://www.prlog.org/11892240-immune-response-biopharma-inc-posts-1st-half-2012-results.htmlImmune Response BioPharma, Inc. Posts 1st Half 2012 Results Highlights include IRBP Granted U.S. Patent 8,053,197 for Auto-Immune Diseases & Plans for a Phase 2B NeuroVax Study and a Phase 3 RAVAX Study for RA.Tue, 05 Jun 2012 09:40:32 GMT http://www.prlog.org/11890800-immune-response-biopharma-inc-plans-listing-on-german-exchanges-to-fund-blockbuster-drug-neurovax.htmlImmune Response BioPharma, Inc. On the Move Plans Listing on German Exchanges to Fund Blockbuster MS Drug NeuroVax & PipelineSun, 03 Jun 2012 06:46:24 GMT http://www.prlog.org/11883928-immune-response-biopharma-terminates-blockbuster-ms-drug-neurovax-partnership-discussions-with-gsk.htmlImmune Response BioPharma, Inc. Terminates Blockbuster MS Drug NeuroVax Partnership Discusions With GSKThu, 24 May 2012 21:24:01 GMT http://www.prlog.org/11873205-immune-response-biopharma-inc-is-granted-us-patent-8053197-for-tcr-peptide-vaccine-technology.htmlImmune Response BioPharma, Inc. announced today that it has received United States Patent Number 8,053,197 expanding coverage relating to its immune-based therapy for Treatment of Auto-Immune Diseases.Sat, 12 May 2012 00:15:18 GMT http://www.prlog.org/11854253-immune-response-biopharma-inc-on-the-move-plans-new-phase-3-ravax-study.html- Immune Response BioPharma, Inc. On the Move Plans New Phase 3 RAVAX Study Immune Response BioPharma, Inc. Today Announces Plans for a New Phase 3 Clinical Study for RAVAX a Vaccine for Rheumatoid Arthritis.Thu, 19 Apr 2012 22:13:48 GMT